PLGA based drug delivery systems (DDS) for the sustained release of insulin: insight into the protein/polyester interactions and the insulin release behavior

BACKGROUND: Drug delivery systems (DDS) were designed using insulin as model drug and poly (lactic–co-glycolic) copolymers (PLGA) as polymeric matrix. The carriers were synthesized by direct self-assembly of the insulin and the polyester under mild conditions. RESULTS: The kind and level of association between the protein and the polymer were studied using computational methods (combined MM2/PM3) and spectroscopic tools (Fourier transform infrared (FTIR), energy dispersive X-ray (EDX) and X-ray fluorescence spectroscopy (XFS)). The effect of the number average molecular weight (Mn) of the copolymer on the association efficiency (AE) drug–polymer as well as on the release profile has been explored. Mathematical models were used to predict the insulin release kinetic and mechanism. CONCLUSIONS: Satisfactory protein/PLGA association efficiencies (between 77 and 99%) were registered depending on the Mn of the PLGA. Hydrophobic and hydrophilic interactions were detected between the protein and the polymeric network by computational analysis. In vitro release studies demonstrated that copolyesters of about 8600 and 1500 Da were suitable for the gradual release of insulin while PLGA oligomers of average molecular weight between 700 and 800 Da were unsuitable as DDS. The insulin release kinetics fits well with the Korsmeyer model, following the anomalous transport mechanism. Copyright © 2010 Society of Chemical Industry

[1]  Nicholas A. Peppas,et al.  A simple equation for description of solute release II. Fickian and anomalous release from swellable devices , 1987 .

[2]  N. Santos-Magalhães,et al.  Colloidal carriers for benzathine penicillin G: nanoemulsions and nanocapsules. , 2000, International journal of pharmaceutics.

[3]  Eric Doelker,et al.  Strategic approaches for overcoming peptide and protein instability within biodegradable nano- and microparticles. , 2005, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[4]  T. Park,et al.  Protein delivery from poly(lactic-co-glycolic acid) biodegradable microspheres: release kinetics and stability issues. , 1998, Journal of microencapsulation.

[5]  K. Tam,et al.  Vesicles from Pluronic/poly(lactic acid) block copolymers as new carriers for oral insulin delivery. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[6]  T. Kissel,et al.  The role of branched polyesters and their modifications in the development of modern drug delivery vehicles. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[7]  Nevin Celebi,et al.  Controlled delivery of peptides and proteins. , 2007, Current pharmaceutical design.

[8]  T. Kissel,et al.  Characterization of a homologous series of D,L-lactic acid oligomers; a mechanistic study on the degradation kinetics in vitro. , 2003, Biomaterials.

[9]  Ponisseril Somasundaran,et al.  ENCYCLOPEDIA OF Surface and Colloid Science , 2006 .

[10]  Ying Zhang,et al.  A novel microgel and associated post-fabrication encapsulation technique of proteins. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[11]  M. L. Ferreira,et al.  Experimental problems in the application of UV/visible based methods as the quantification tool for the entrapped/released insulin from PLGA carriers , 2009 .

[12]  M. L. Ferreira,et al.  Lipase-catalyzed copolymerization of lactic and glycolic acid with potential as drug delivery devices , 2008, Bioprocess and biosystems engineering.

[13]  D. K. Majumdar,et al.  Insulin Loaded Eudragit L100 Microspheres for Oral Delivery: Preliminary in vitro Studies , 2006, Journal of biomaterials applications.

[14]  R. Bodmeier,et al.  A novel in situ forming drug delivery system for controlled parenteral drug delivery. , 2007, International journal of pharmaceutics.

[15]  J. Benoit,et al.  How to achieve sustained and complete protein release from PLGA-based microparticles? , 2008, International journal of pharmaceutics.

[16]  T. Kissel,et al.  Self-assembling nanocomplexes from insulin and water-soluble branched polyesters, poly[(vinyl-3-(diethylamino)- propylcarbamate-co-(vinyl acetate)-co-(vinyl alcohol)]-graft- poly(L-lactic acid): a novel carrier for transmucosal delivery of peptides. , 2004, Bioconjugate chemistry.

[17]  Nicholas A. Peppas,et al.  A simple equation for description of solute release I. Fickian and non-fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs , 1987 .

[18]  Lynne S. Taylor,et al.  Spectroscopic Characterization of Interactions Between PVP and Indomethacin in Amorphous Molecular Dispersions , 1997, Pharmaceutical Research.

[19]  Themistoklēs P. Chatzēiōannou,et al.  Quantitative calculations in pharmaceutical practice and research , 1993 .

[20]  A. Domb,et al.  Stereocomplexes based on poly(lactic acid) and insulin: formulation and release studies. , 2002, Biomaterials.

[21]  Yoshinori Onuki,et al.  Current challenges in non-invasive insulin delivery systems: a comparative review. , 2007, Advanced drug delivery reviews.

[22]  A. Lesk,et al.  How different amino acid sequences determine similar protein structures: the structure and evolutionary dynamics of the globins. , 1980, Journal of molecular biology.

[23]  Shen‐guo Wang,et al.  Fabrication and biocompatibility of cell scaffolds of poly(L-lactic acid) and poly(L-lactic-co-glycolic acid) , 2002 .

[24]  R. W. Baker,et al.  THEORY AND PRACTICE OF CONTROLLED DRUG DELIVERY FROM BIOERODIBLE POLYMERS , 1980 .

[25]  Nikolaos A. Peppas,et al.  Solute and penetrant diffusion in swellable polymers. I. Mathematical modeling , 1986 .

[26]  N A Peppas,et al.  Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). , 2001, Advanced drug delivery reviews.

[27]  A. Barth.  Infrared spectroscopy of proteins. , 2007, Biochimica et biophysica acta.

[28]  P. Dubin,et al.  Binding of proteins to copolymers of varying hydrophobicity. , 1999, Biopolymers.

[29]  Y. Kawashima,et al.  Biodegradable nanoparticles loaded with insulin-phospholipid complex for oral delivery: preparation, in vitro characterization and in vivo evaluation. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[30]  Fabiana Quaglia,et al.  Bioinspired tissue engineering: the great promise of protein delivery technologies. , 2008, International journal of pharmaceutics.

[31]  V. Calhoun,et al.  Controlled release of bioactive materials. , 1980 .

[32]  Nicholas A. Peppas,et al.  Solute and penetrant diffusion in swellable polymers. II. Verification of theoretical models , 1986 .

[33]  G. Spadaro,et al.  Cytarabine release from α,β-poly(N-hydroxyethyl)-dl-aspartamide matrices cross-linked through γ-radiation , 1996 .

[34]  G. Boering,et al.  Resorbable materials of poly(L-lactide). VII. In vivo and in vitro degradation. , 1987, Biomaterials.

[35]  M Levitt,et al.  Recognizing native folds by the arrangement of hydrophobic and polar residues. , 1995, Journal of molecular biology.

[36]  T. Park,et al.  A new preparation method for protein loaded poly(D, L-lactic-co-glycolic acid) microspheres and protein release mechanism study. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[37]  T. Higuchi.  MECHANISM OF SUSTAINED-ACTION MEDICATION. THEORETICAL ANALYSIS OF RATE OF RELEASE OF SOLID DRUGS DISPERSED IN SOLID MATRICES. , 1963, Journal of pharmaceutical sciences.

[38]  J. Ma,et al.  Preparation of insulin nanoparticles and their encapsulation with biodegradable polyelectrolytes via the layer-by-layer adsorption. , 2006, International journal of pharmaceutics.

[39]  R. Bodmeier,et al.  Myotoxicity studies of O/W-in situ forming microparticle systems. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[40]  A. W. Hixson,et al.  Dependence of Reaction Velocity upon surface and Agitation , 1931 .

[41]  J. E. Puig,et al.  Theophylline release from poly(acrylic acid-co-acrylamide) hydrogels , 1999 .

[42]  N. Peppas,et al.  Analysis of non-fickian transport in polymers using simplified exponential expressions , 1984 .

[43]  T. Kissel,et al.  On the design of in situ forming biodegradable parenteral depot systems based on insulin loaded dialkylaminoalkyl-amine-poly(vinyl alcohol)-g-poly(lactide-co-glycolide) nanoparticles. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[44]  C. Tribet,et al.  Association between Hydrophobically Modified Polyanions and Negatively Charged Bovine Serum Albumin , 1998 .

[45]  Tae Gwan Park,et al.  Importance of in vitro experimental conditions on protein release kinetics, stability and polymer degradation in protein encapsulated poly (d,l-lactic acid-co-glycolic acid) microspheres , 1995 .

[46]  L. Dong,et al.  Characterization of physiochemical and biological properties of an insulin/lauryl sulfate complex formed by hydrophobic ion pairing. , 2007, International journal of pharmaceutics.

[47]  Chi-Hwa Wang,et al.  Mathematical modeling and simulation of drug release from microspheres: Implications to drug delivery systems. , 2006, Advanced drug delivery reviews.

[48]  R. Bodmeier,et al.  Influence of the poly(lactide-co-glycolide) type on the leuprolide release from in situ forming microparticle systems. , 2006, Journal of controlled release : official journal of the Controlled Release Society.